CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Probe Breath Biopsy Test to differentiate between individuals with lung cancer and relevant contrast groups.The contrast groups wil...
Phase 2
Budapest, Hungary and 8 other locations
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...
Phase 2
Budapest, Hungary and 83 other locations
to docetaxel in participants with advanced non-small cell lung cancer (NSCLC) harboring a KRAS G12C mutation who have been previous...
Phase 3
Budapest, Hungary and 65 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
Budapest, Hungary and 209 other locations
with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...
Phase 3
Budapest, Hungary and 210 other locations
protein 4 \[CTLA4\] antibody \[another investigational medicinal product\]) in patients with advanced or metastasized non-small cell lung ca...
Phase 1
Budapest, Hungary and 37 other locations
, early-stage non-small cell lung cancer....
Phase 2
Törökbálint, Hungary and 94 other locations
In the SAMSON-2 study, the proposed biosimilar HD204 will be compared to its reference product EU-licensed Avastin®. The aim of the study is to demon...
Phase 3
Törökbálint, Hungary and 17 other locations
The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the ...
Phase 3
Budapest, Hungary and 219 other locations
and safety of platinum-based chemotherapy with or without INCMGA00012 in participants with metastatic squamous and nonsquamous non-small cell lung...
Phase 3
Budapest, Hungary and 140 other locations
Clinical trials
Research sites
Resources
Legal